EOSINOPHILIC GASTROENTERITIS
Clinical trials for EOSINOPHILIC GASTROENTERITIS explained in plain language.
Never miss a new study
Get alerted when new EOSINOPHILIC GASTROENTERITIS trials appear
Sign up with your email to follow new studies for EOSINOPHILIC GASTROENTERITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for rare gut disorder
Disease control CompletedThis Phase 3 study tested an investigational drug called CC-93538 for adults and adolescents in Japan with eosinophilic gastroenteritis, a rare inflammatory gut disease. The trial aimed to see if the drug could reduce gut inflammation and improve symptoms like stomach pain, heavi…
Matched conditions: EOSINOPHILIC GASTROENTERITIS
Phase: PHASE3 • Sponsor: Celgene • Aim: Disease control
Last updated Apr 02, 2026 05:11 UTC
-
New injection tested for rare stomach disease
Disease control CompletedThis study tested whether dupilumab, an injectable medication, could reduce harmful inflammation in the stomachs of people with eosinophilic gastritis. Forty-one participants aged 12-70 received either the drug or a placebo injection every two weeks for 12 weeks. The main goal wa…
Matched conditions: EOSINOPHILIC GASTROENTERITIS
Phase: PHASE2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Mar 09, 2026 14:26 UTC
-
Could a common nausea pill make colonoscopy prep easier for kids?
Symptom relief CompletedThis study tested if adding an anti-nausea medicine (ondansetron) to the standard laxative drink could make the colonoscopy preparation process easier for children and teens. The goal was to see if reducing nausea and discomfort helped patients finish the prep drink, leading to a…
Matched conditions: EOSINOPHILIC GASTROENTERITIS
Phase: PHASE4 • Sponsor: State University of New York - Downstate Medical Center • Aim: Symptom relief
Last updated Mar 30, 2026 14:32 UTC